DMT — Small Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$48.67m
- CA$41.47m
Annual cashflow statement for Small Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2020 February 28th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final |
| Net Income/Starting Line | -0.744 | -7.02 | -22.3 | -22.8 |
| Depreciation | ||||
| Non-Cash Items | -0 | 1.98 | 4.49 | 1.23 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.165 | -0.421 | 1.52 | -0.655 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.578 | -5.46 | -16.2 | -22.2 |
| Capital Expenditures | -0.001 | -0.073 | -0.013 | -0.029 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | 0.001 | -2.39 | 2.5 |
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.001 | -0.072 | -2.4 | 2.47 |
| Financing Cash Flow Items | -0 | 1.9 | — | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.01 | 10.6 | 53.9 | -0.436 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.432 | 5.05 | 34.9 | -22.1 |